Development and Commercialization License. Subject to the terms of this Agreement, Atugen hereby grants to QBI an exclusive, royalty bearing, world-wide license, with the right to sublicense as set forth in Section 6.3 under the Atugen Existing IP and the Joint Program IP, to develop, use, manufacture and/or have manufactured, import, market, sell and otherwise commercialize QBI Products.
Appears in 2 contracts
Samples: Collaboration Agreement (Quark Pharmaceuticals Inc), Collaboration Agreement (Quark Biotech Inc)
Development and Commercialization License. Subject to the terms of this Agreement, Atugen QBI hereby grants to QBI Atugen an exclusive, royalty bearing, world-wide license, license with the right to sublicense as set forth in Section 6.3 6.3, under the Atugen QBI Existing IP and the Joint Program IP, to develop, use, manufacture and/or have manufactured, manufactured and commercialize import, market, sell and otherwise commercialize QBI Atugen Products.
Appears in 1 contract
Development and Commercialization License. Subject to the terms of this Agreement, Atugen QBI hereby grants to QBI Atugen an exclusive, royalty bearing, world-wide license, license with the right to sublicense as set forth in Section 6.3 6.3, under the Atugen QBI Existing IP and the Joint Program IP, to develop, use, manufacture manuf acture and/or have manufactured, manufactured and commercialize import, market, sell and otherwise commercialize QBI Atugen Products.
Appears in 1 contract
Samples: Collaboration Agreement (Quark Pharmaceuticals Inc)
